What is the long-term trend for Perspective Therapeutics's income from discontinued ops?

Over 2 years (2023 to 2025), Perspective Therapeutics's income from discontinued ops has grown at a -76.2% compound annual growth rate (CAGR), from -$9.05M to $514K.

What does income from discontinued ops mean?

Gains or losses from business segments that have been sold, abandoned, or classified as held for sale, reported net of applicable income taxes.

Perspective Therapeutics CATX Income from Discontinued Ops

Income from Discontinued Ops at other companies

Liberty Broadband CorporationLBRDK

$0.02-84.6%

Sonoco ProductsSON

$0-100%

Kontoor Brands, Inc.KTB

$0.57-3.4%

H&R BlockHRB

-$879K-47.0%

RayonierRYN

$0.00-100%

TFX

TeleflexTFX

-$3.32M-108%

Other financials

Income statement

See full

Revenue$2.2M+27.3%

Gross profit$738.0K+78.3%

Operating income-$28.3M-29.5%

Net income-$26.2M-44.1%

EPS (diluted)-$0.250.0%

Balance sheet

See full

Cash & equivalents$54.0M+21.5%

Total debt$4.2M+10.9%

Total equity$347.4M+22.1%

Total assets$410.8M+24.7%

Cash flow

See full

Operating cash flow-$31.5M-45.8%

CapEx$6.9M+47.3%

Free cash flow-$38.3M-46.1%

Valuation

See full

Market cap$342.14M+33.2%

Enterprise value$292.34M+35.2%

P/S34.2×+19.6×

Profitability

See full

Gross margin33.1%-7.1pp

Operating margin-292.7%-553pp

Net margin-218.4%-781pp

FCF margin-1,073.3%—

Returns & leverage

See full

Return on equity-35.2%+2.3pp

Debt / equity0×0.0×

Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax.

The official record: Perspective Therapeutics’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's income from discontinued ops.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Perspective Therapeutics's income from discontinued ops?: Perspective Therapeutics (CATX) reported income from discontinued ops of $0 in Q4 2025.
What is the long-term trend for Perspective Therapeutics's income from discontinued ops?: Over 2 years (2023 to 2025), Perspective Therapeutics's income from discontinued ops has grown at a -76.2% compound annual growth rate (CAGR), from -$9.05M to $514K.
What does income from discontinued ops mean?: Gains or losses from business segments that have been sold, abandoned, or classified as held for sale, reported net of applicable income taxes.